Evaluating the economic implications of cardiovascular therapeutics
Fundamentals of economic analysis
Role of economic models in randomized clinical trials
Statistical issues in cost-effectiveness analysis
Terminology I would like to see disappear
A survey of standards and guidelines for cost-effectiveness analysis in health care*
What constitutes a useful health economic study for the pharmaceutical industry?
What constitutes a useful economic study? The health systems perspective
Consortium perspective: What constitutes a useful economic study?
Role of government agencies regarding cost-effectiveness claims: FDA perspective
Product labeling and pharmacoeconomic information
The value of cost-effectiveness analyses for reimbursement decisions: Perspectives from Medicare
Thrombolytic therapy: Economic considerations
The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies: A health system perspective on thrombolytic therapy for acute myocardial infarction
Comparative economic data regarding lipid-lowering drugs
Economics and cost-effectiveness in evaluating the value of cardiovascular therapy: Lipid-lowering therapies - an industry perspective
Lipid-lowering drugs, cost-effectiveness data, and the formulary system: A health systems perspective
ACE inhibitors in the management of congestive heart failure: Comparative economic data
Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective
Use of abciximab: Comparative economic data
Health system perspective regarding glycoprotein IIb/IIIa inhibitor therapy
An industry perspective on health economics studies
Evaluation of the cost-effectiveness of coronary stenting: A societal perspective
Coronary stents: An industry perspective
Coronary stents: A health system perspective